Search
Spero Therapeutics Inc
SPROAdd to Watchlist
2.280USD
+0.170+8.06%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
132.02MMarket Cap
8.21P/E TTM
Spero Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Spero Therapeutics Inc is 6.60, ranking 317 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 8.21, which is 127.62% below the recent high of 18.69 and 149.41% above the recent low of -4.06.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
